Archive · 7 Sep 2025
Billionaires Invest Billions in Quest for Longer, Healthier Lives
Some very rich people are putting billions of dollars into companies that want to help us live longer and healthier lives.
They are hoping to find ways to slow down aging or even reverse it.
Investors include famous names from tech like Peter Thiel.
They're looking at different approaches, like cell rejuvenation and treatments for diseases of aging.
The investors often have personal reasons, such as the loss of a loved one.
Many are betting on scientific advancements to make it possible for people to live much longer, possibly past 100 years old.
Companies in this field are raising large amounts of money to fund their research and development.
Ultrawealthy investors have invested over $5 billion in longevity research over the past 25 years.
Peter Thiel, Sam Altman, and other tech leaders are major investors in this field.
Companies are focusing on cell rejuvenation, treatments for age-related diseases, and health services.
The average fundraising round for longevity companies has grown significantly.
Many investors are motivated by personal reasons and the potential for significant returns.
- Who
- Ultrawealthy investors, including Peter Thiel and Sam Altman
- What
- Investing in companies to extend and improve human lifespan
- When
- Over the past 2.5 decades, with increasing investment recently
- Where
- Silicon Valley and other areas with biotech and longevity research
- Why
- Personal motivations and the potential for significant returns
- Total Investment
- Over $5 billion in 2.5 decades
- Key Investors
- Peter Thiel, Sam Altman, Yuri Milner, Marc Andreessen
- Companies Focused On
- Cell rejuvenation, age-related disease treatment, health services
- Average Fundraising Round
- Nearly $43 million